INTRODUCTION: To compare postoperative visual acuity (VA), intraocular pressure (IOP), endothelial cell density and anterior chamber cell numbers of patients who received either intracameral cefuroxime or moxifloxacin at the end of cataract surgery. METHODS: Fifty five eyes of 42 patients who underwent cataract surgery between March 2008 and March 2009 in the Eye Clinic of Haydarpasa Numune Education and Research Hospital were included in the study. Eyes that received intracameral cefuroxime or moxifloxacin at the end of cataract surgery were evaluated. Preoperative and postoperative VA, IOP values, endothelial cell density and anterior chamber cell numbers of the patients were recorded. RESULTS: Twenty of the patients were male and 22 of them were female. Their average age was 52.18 ± 4.25 years. Mean age of first (cefuroxime) and second (moxifloxacin) group patients was 43.34 ± 7.19 and 60.1 ± 4.72 years respectively. While there was 26 eyes of 21 patients in the first group, 29 eyes of 21 patients were in the second group.. No statistically significant difference was found in both groups regarding age, pre- and postoperative VA and IOP values, endothelial cell density, anterior chamber cell amount and follow-up time (p> 0.05). DISCUSSION AND CONCLUSION: There was no significant difference in postoperative VA, IOP, anterior chamber cell count and endothelial cell density between patients who received cefuroxime and moxifloxacin to the anterior chamber at end of cataract surgery for endophthalmitis prophylaxis.
To compare postoperative visual acuity (VA), intraocular pressure (IOP), endothelial cell density and anterior chamber cell numbers of patients who received either intracameral cefuroxime or moxifloxacin at the end of cataract surgery. METHODS: Fifty five eyes of 42 patients who underwent cataract surgery between March 2008 and March 2009 in the Eye Clinic of Haydarpasa Numune Education and Research Hospital were included in the study. Eyes that received intracameral cefuroxime or moxifloxacin at the end of cataract surgery were evaluated. Preoperative and postoperative VA, IOP values, endothelial cell density and previous chamber cell numbers of the patients were recorded. Twenty of the patients were male and 22 of them were female. Their average age was 52.18 ± 4. 25 years ago. Mean age of first (cefuroxime) and second (moxifloxacin) group patients was 43.34 ± 7.19 and 60.1 ± 4.72 years respectively. While there were 26 eyes of 21 patients in the first group, 29 eyes of 21 patients were in the second group.. No statistically significant difference was found in both groups regarding age, pre- and postoperative VA and IOP values, endothelial cell density, anterior chamber cell amount and follow-up time (p> 0.05). DISCUSION AND CONCLUSION: There was no significant difference in postoperative VA, IOP, anterior chamber cell count and endothelial cell density between patients who received cefuroxime and moxifloxacin to the previous chamber at the end of cataract surgery for endophthalmitis prophylaxis.
Alan : Sağlık Bilimleri
Dergi Türü : Ulusal
Benzer Makaleler | Yazar | # |
---|
Makale | Yazar | # |
---|